Simon Baker
Stock Analyst at Redburn Atlantic
(0.85)
# 3,733
Out of 4,854 analysts
8
Total ratings
25%
Success rate
-5.9%
Average return
Main Sectors:
Stocks Rated by Simon Baker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AUTL Autolus Therapeutics | Upgrades: Buy | $13 | $2.34 | +455.56% | 1 | Nov 15, 2024 | |
| BNTX BioNTech SE | Upgrades: Buy | $165 → $170 | $108.49 | +56.70% | 3 | May 17, 2023 | |
| QGEN Qiagen | Initiates: Buy | n/a | $45.48 | - | 1 | Oct 14, 2021 | |
| ABT Abbott Laboratories | Initiates: Neutral | n/a | $133.58 | - | 1 | Oct 14, 2021 | |
| HOLX Hologic | Initiates: Neutral | n/a | $64.33 | - | 1 | Oct 14, 2021 | |
| FOXA Fox Corporation | Upgrades: Hold | $29 → $24 | $54.37 | -55.86% | 1 | Apr 8, 2020 |
Autolus Therapeutics
Nov 15, 2024
Upgrades: Buy
Price Target: $13
Current: $2.34
Upside: +455.56%
BioNTech SE
May 17, 2023
Upgrades: Buy
Price Target: $165 → $170
Current: $108.49
Upside: +56.70%
Qiagen
Oct 14, 2021
Initiates: Buy
Price Target: n/a
Current: $45.48
Upside: -
Abbott Laboratories
Oct 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $133.58
Upside: -
Hologic
Oct 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $64.33
Upside: -
Fox Corporation
Apr 8, 2020
Upgrades: Hold
Price Target: $29 → $24
Current: $54.37
Upside: -55.86%